Trial | NCT02235844  Report issue

Title

Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
Allogeneic Transplantation of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    1
This research study is designed to evaluate the effects of human umbilical cord mesenchymal stem cells (UC-MSCs), on Duchenne's muscular dystrophy (DMD). The potential muscle regenerative and anti-inflammatory properties of UC MSCs position them as a possible treatment option for DMD. Both of these properties could lead to potential benefits for a DMD patient.
Study Started
Sep 30
2014
Primary Completion
Sep 30
2017
Study Completion
Sep 30
2017
Last Update
Sep 16
2019

Biological Umbilical Cord Mesenchymal Stem Cells

Mesenchymal Stem Cells Experimental

Umbilical Cord Mesenchymal Stem Cells

Criteria 

Inclusion Criteria:

Duchenne's Muscular Dystrophy

Exclusion Criteria:

None
No Results Posted